Evidence map›Paper›PMID 28035988›Full record

ReviewMolecules (Basel, Switzerland)2016

Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches.

Anthony Ayodeji Adegoke, Adekunle Christopher Faleye, Gulshan Singh, Thor Axel Stenström

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. A Saudi Arabian Public Health Perspective of Tuberculosis.International journal of environmental research and public health · 2021
    Review
  16. Molecular Topology for the Search of New Anti-MRSA Compounds.International journal of molecular sciences · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anthony Ayodeji AdegokeSARChI, Institute for Water and Wastewater Technology, Durban University of Technology, Durban 4000, South Africa. anthonya1@dut.ac.za.
Adekunle Christopher FaleyeSARChI, Institute for Water and Wastewater Technology, Durban University of Technology, Durban 4000, South Africa. kunle_faleye@yahoo.co.uk.
Gulshan SinghSARChI, Institute for Water and Wastewater Technology, Durban University of Technology, Durban 4000, South Africa. gsingh.gulshan@gmail.com.
Thor Axel StenströmSARChI, Institute for Water and Wastewater Technology, Durban University of Technology, Durban 4000, South Africa. thors@dut.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing threat to global health posed by antibiotic resistance remains of serious concern. Human health remains at higher risk due to several reported therapeutic failures to many life threatening drug resistant microbial infections. The resultant effects have been prolonged hospital stay, higher cost of alternative therapy, increased mortality, etc. This opinionated review considers the two main concerns in integrated human health risk assessment (i.e., residual antibiotics and antibiotic resistant genes) in various compartments of human environment, as well as clinical dynamics associated with the development and transfer of antibiotic resistance (AR). Contributions of quorum sensing, biofilms, enzyme production, and small colony variants in bacteria, among other factors in soil, water, animal farm and clinical settings were also considered. Every potential factor in environmental and clinical settings that brings about AR needs to be identified for the summative effects in overall resistance. There is a need to embrace coordinated multi-locational approaches and interrelationships to track the emergence of resistance in different niches in soil and water versus the hospital environment. The further integration with advocacy, legislation, enforcement, technological innovations and further research input and recourse to WHO guidelines on antibiotic policy would be advantageous towards addressing the emergence of antibiotic resistant superbugs.

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, Multiple, BacterialEnvironmentHumansMicrobial Sensitivity TestsSoil MicrobiologyWater MicrobiologyAnti-Bacterial Agentsantimicrobial resistancecritical control pointexposurehealth risk assessmentresidual antibioticssuperbugtotal antibiotic resistance

Identifiers

PMID28035988
PMCPMC6155606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.